Additionally, ADAM19 showed a significantly higher expression in C1–C3 of BLCA and KIRC, whereas ADAM8 was highly expressed in C6 of BLCA and KIRC. This evidence concerns the gene ADAM8 and bladder transitional cell carcinoma.